Want to join the conversation?
$MS' compensation and benefits expenses for 2015 decreased by 10% from last year. This decline was primarily due to the 2014 compensation actions, a decrease in 2015 in the fair value of deferred compensation plan referenced investments and carried interest, and a fall in the level of discretionary incentive compensation in 2015.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.